Primary Care

Steven E. Nissen, MD, lead author of the study “Bempedoic Acid And Cardiovascular Outcomes In Statin-Intolerant Patients,” answers questions on the importance of his team’s research on bempedoic acid, how...

Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...

In this Q&A, W. Clay Jackson, MD, DipTH, speaks about various aspects of schizophrenia, including the symptoms, risk factors, and associated controversies surrounding these risk factors.

Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.

In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...

In this Q&A, W. Clay Jackson, MD, answers questions about the positive and negative symptoms, the therapeutic challenges, the gold standard of treatment of patients with schizophrenia, and some...

Passive smoking exposure is known to cause adverse health outcomes, but what is the association between passive smoking exposure and the risk of hypertension? In this Q&A, Onoja Apka, PhD, answered...

As influenza vaccination rates among health care workers often fall at substandard levels, mandatory vaccination has been proposed. In this Q&A, Gianluca Voglino, MD, discusses his team’s findings on the...

Despite being approved for use by the FDA in 2019, many questions remain on the safety, tolerability, and efficacy of ubrogepant in certain patient populations with migraine in the real-world population....

Consultant360 spoke with Oyunbileg Magvanjav, MD, PhD, and Julie A. Johnson, PharmD, whose recent study examined trends in the use of recommended dual antihypertensive therapy options.